April 29th 2025
Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with rheumatoid arthritis (RA).
Dr William "Andy" Nish on Increasing Medication Adherence for Asthma Therapies
September 5th 2021Using the argument that regularly taking medication is a great way to earn parents' trust is a great tactic to encourage children and teenagers to remain adherent to their asthma therapies, said William "Andy" Nish, MD, an allergist and immunologist in Georgia.
Watch
Multidisciplinary Approach Important for Successful HCC Care
September 4th 2021Hepatocellular carcinoma (HCC) is challenging to diagnose and has an evolving treatment landscape, which makes a multidisciplinary approach to care important to ensure high-quality care and the best patient outcomes.
Read More
A new Texas law ending abortions after 6 weeks takes effect, angering the American College of Obstetricians and Gynecologists; the CDC says mortality rates may not go back to normal until 2023; a Senate version of a bill aimed at lowering drug prices would only impact Medicare.
Read More
ERS 2021: COVID-19 Takes Spotlight, With Climate Change Another Focus
August 31st 2021The European Respiratory Society International Congress 2021 will feature a wide array of topics, such as gender and respiratory health, the impact of climate change, and management and treatment of chronic cough, but there remains a strong focus on the COVID-19 pandemic, its intersection with respiratory care and treatment of infection.
Read More
Outreach, Engagement, Inclusion Infuse the Work of Georgia’s SisterLove Inc
August 30th 2021In 1989, in Atlanta, Georgia, Dázon Dixon Diallo established SisterLove Inc to fill the information and education gap many women, especially Black women, were facing on how the emerging HIV/AIDS epidemic could affect them.
Read More
Two people dead after receiving potentially contaminated Moderna COVID-19 vaccines in Japan; Biogen offers its controversial and expensive Alzheimer disease treatment for free to boost prescriptions; COVID-19 infection with the Delta variant may more than double the risk of hospitalization.
Read More
Dr Rajesh Rajpal on Eye Health Implications of Visual Needs in Younger Populations
August 27th 2021Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses how greater visual needs are contributing to adverse eye health in younger populations.
Watch
Foundation Medicine, Epic Partner on Access to Genomic Profiling in EHRs
August 26th 2021Foundation Medicine and Epic struck a deal to integrate comprehensive genomic profiling within Epic's electronic health records (EHRs), allowing for providers to order and review genomic profiling tests, leading to more streamlined clinical decision making.
Read More
Improved Immunotherapy Education Needed for Patients to Grasp Benefits, Risks
August 25th 2021Survey responses from patients with advanced cancer revealed that there were gaps in knowledge across various aspects of immunotherapy treatment, including about side effects and curative potential.
Read More
Study Finds Home-Based Postoperative Management of Deep Brain Stimulation Safe, Effective
August 23rd 2021Postoperative management of deep brain stimulation in patients with Parkinson disease was shown to be safe and effective when administered at home, which may reduce necessity of in-clinic visits and care access issues.
Read More
Aflibercept Likely to Improve Severity, Complications of Nonproliferative Diabetic Retinopathy
August 21st 2021Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 weeks and the likelihood of vision-threatening complications significantly reduced.
Read More
Low Safety Risk Observed in Office-Based, Operating Room Anti-VEGF Intravitreal Injections
August 19th 2021A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate of culture-positive endophthalmitis found in the office setting.
Read More
AHA Releases Scientific Statement on OSA, Cardiovascular Disease Link in Children and Adolescents
August 18th 2021The scientific statement addresses current knowledge regarding the impact of obstructive sleep apnea on the cardiovascular health of children and adolescents, as well as best practices to evaluate symptoms.
Read More
Addressing Pay-for-Delay Deals, Anticompetition in the Pharmaceutical Industry
August 17th 2021Despite executive orders by the Biden administration aimed to improve competition in the pharmaceutical industry, pay-for-delay deals and other antitrust issues continue to be reported. On this episode of Managed Care Cast, we speak on the history and prevalence of these anticompetitive tactics and steps to limit these deals.
Listen
After 3 Months of Decline, Telehealth Utilization Stabilizes in May 2021
August 12th 2021Telehealth utilization stabilized in May 2021 after a 3-month drop, according to FAIR Health’s Monthly Telehealth Regional Tracker. Robin Gelburd, JD, president of FAIR Health, discusses the stabilization of telehealth utilization in May 2021 after a 3-month drop.
Read More
Exploring 2022 Trends in Health and Hospital Drug Spending With Vizient
August 10th 2021Vizient recently released its Summer 2021 Pharmacy Market Outlook, which projects pharmaceutical spending for 2022 based on an analysis of its members' data. On this episode of Managed Care Cast, we talk about some of the findings.
Listen
Monitoring MRD Can Help Diagnose Cutaneous T-Cell Lymphoma
August 5th 2021Researchers were able to use a next-generation sequencing assay to not only monitor minimal residual disease (MRD), but also to confirm diagnosis of cutaneous T-cell lymphoma, which can present as more benign conditions early on.
Read More
Diagnose, Monitor, Treat: How AI’s 3-Pronged Approach Can Help to Propel Progress in MS
August 5th 2021Using artificial intelligence (AI) effectively may help to revolutionize the diagnosis, monitoring, and treatment of multiple sclerosis (MS), as well as optimizing understanding of the immune-mediated disease.
Read More